148 related articles for article (PubMed ID: 38482714)
21. Metastasectomy for recurrent or metastatic biliary tract cancers: A single center experience.
Park I; Kim YS; Sym SJ; Ahn HK; Kim KK; Park YH; Lee JN; Shin DB
Indian J Cancer; 2017; 54(1):57-62. PubMed ID: 29199665
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of biliary tract cancers.
Fairweather M; Balachandran VP; D'Angelica MI
Chin Clin Oncol; 2016 Oct; 5(5):63. PubMed ID: 27829277
[TBL] [Abstract][Full Text] [Related]
23. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer.
Shen N; Zhang D; Yin L; Qiu Y; Liu J; Yu W; Fu X; Zhu B; Xu X; Duan A; Chen Z; Wang X; Cao X; Zhao T; Zhou Z; Yu L; Qin H; Fang Z; Li JY; Liu Y; Xiong L; Yuan B; Li F; Zhang Y
Oncol Rep; 2019 Aug; 42(2):549-560. PubMed ID: 31173267
[TBL] [Abstract][Full Text] [Related]
24. Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes.
Qiu Z; Ji J; Xu Y; Zhu Y; Gao C; Wang G; Li C; Zhang Y; Zhao J; Wang C; Wen X; Zhang Z; Li B; Zhang Z; Cai S; Li B; Jiang X
BMC Med; 2022 Feb; 20(1):64. PubMed ID: 35130881
[TBL] [Abstract][Full Text] [Related]
25. Surgical outcomes of multicentric adenocarcinomas of the biliary tract.
Kobayashi S; Konishi M; Kato Y; Gotohda N; Takahashi S; Kinoshita T; Kinoshita T; Kojima M
Jpn J Clin Oncol; 2011 Sep; 41(9):1079-85. PubMed ID: 21875937
[TBL] [Abstract][Full Text] [Related]
26. Classifying extrahepatic bile duct metachronous carcinoma by de novo neoplasia site.
Kwon HJ; Kim SG; Chun JM; Hwang YJ
World J Gastroenterol; 2014 Mar; 20(11):3050-5. PubMed ID: 24659897
[TBL] [Abstract][Full Text] [Related]
27. Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients.
Conci S; Ruzzenente A; Simbolo M; Bagante F; Rusev B; Isa G; Lawlor RT; Pedrazzani C; Iacono C; Guglielmi A; Scarpa A
Updates Surg; 2020 Mar; 72(1):119-128. PubMed ID: 32020551
[TBL] [Abstract][Full Text] [Related]
28. Genomics driven precision oncology in advanced biliary tract cancer improves survival.
Kumar-Sinha C; Vats P; Tran N; Robinson DR; Gunchick V; Wu YM; Cao X; Ning Y; Wang R; Rabban E; Bell J; Shankar S; Mannan R; Zhang Y; Zalupski MM; Chinnaiyan AM; Sahai V
Neoplasia; 2023 Aug; 42():100910. PubMed ID: 37267699
[TBL] [Abstract][Full Text] [Related]
29. The epidemiological trends of biliary tract cancers in the United States of America.
Jiang Y; Jiang L; Li F; Li Q; Yuan S; Huang S; Fu Y; Yan X; Chen J; Li H; Li S; Liu J
BMC Gastroenterol; 2022 Dec; 22(1):546. PubMed ID: 36581813
[TBL] [Abstract][Full Text] [Related]
30. Genetic assessment of recurrent pancreatic high-risk lesions in the remnant pancreas: Metachronous multifocal lesion or local recurrence?
Gotoh Y; Ohtsuka T; Nakamura S; Shindo K; Ohuchida K; Miyasaka Y; Mori Y; Mochidome N; Oda Y; Nakamura M
Surgery; 2019 Apr; 165(4):767-774. PubMed ID: 30497813
[TBL] [Abstract][Full Text] [Related]
31. Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone.
Kagoura M; Kobayashi S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N
Eur J Surg Oncol; 2024 Mar; 50(3):107980. PubMed ID: 38281442
[TBL] [Abstract][Full Text] [Related]
32. The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
Berchuck JE; Facchinetti F; DiToro DF; Baiev I; Majeed U; Reyes S; Chen C; Zhang K; Sharman R; Uson Junior PLS; Maurer J; Shroff RT; Pritchard CC; Wu MJ; Catenacci DVT; Javle M; Friboulet L; Hollebecque A; Bardeesy N; Zhu AX; Lennerz JK; Tan B; Borad M; Parikh AR; Kiedrowski LA; Kelley RK; Mody K; Juric D; Goyal L
Ann Oncol; 2022 Dec; 33(12):1269-1283. PubMed ID: 36089135
[TBL] [Abstract][Full Text] [Related]
33. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
[TBL] [Abstract][Full Text] [Related]
34. Intraductal tubular neoplasms of the bile ducts.
Katabi N; Torres J; Klimstra DS
Am J Surg Pathol; 2012 Nov; 36(11):1647-55. PubMed ID: 23073323
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of bile-derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers.
Yoshida M; Yukawa H; Hayashi K; Naitoh I; Miyabe K; Hori Y; Natsume M; Jinno N; Kato A; Kachi K; Asano G; Sahashi H; Toyohara T; Kuno K; Kito Y; Kondo H; Hirano A; Okumura F; Anbe K; Baba Y; Kataoka H; Tanaka Y
Cancer Sci; 2023 Jan; 114(1):295-305. PubMed ID: 36168845
[TBL] [Abstract][Full Text] [Related]
36. Intraductal neoplasms of the bile duct. A new challenge to biliary tract tumor pathology.
Nakanuma Y; Uesaka K; Miyayama S; Yamaguchi H; Ohtsuka M
Histol Histopathol; 2017 Oct; 32(10):1001-1015. PubMed ID: 28337739
[TBL] [Abstract][Full Text] [Related]
37. Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective.
Neuzillet C; Artru P; Assenat E; Edeline J; Adhoute X; Sabourin JC; Turpin A; Coriat R; Malka D
Target Oncol; 2023 Jan; 18(1):51-76. PubMed ID: 36745342
[TBL] [Abstract][Full Text] [Related]
38. HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples.
Loi E; Zavattari C; Tommasi A; Moi L; Canale M; Po A; Sabato C; Vega-Benedetti AF; Ziranu P; Puzzoni M; Lai E; Faloppi L; Rullán M; Carrascosa J; Amat I; Urman JM; Arechederra M; Berasain C; Ferretti E; Casadei-Gardini A; Avila MA; Alonso S; Scartozzi M; Zavattari P
Br J Cancer; 2022 Jun; 126(12):1783-1794. PubMed ID: 35177798
[TBL] [Abstract][Full Text] [Related]
39. Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer.
Hiraoka N; Nitta H; Ohba A; Yoshida H; Morizane C; Okusaka T; Nara S; Esaki M; Kishi Y; Shimada K
Hum Pathol; 2020 Nov; 105():9-19. PubMed ID: 32891647
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic study on metachronous double cholangiocarcinomas of perihilar and subsequent distal bile duct origin.
Shinohara K; Shimoyama Y; Ebata T; Yokoyama Y; Mizuno T; Nakaguro M; Nagino M
Surgery; 2017 Jul; 162(1):84-93. PubMed ID: 28187867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
